Make confident decisions faster
using comprehensive evidence.

Human expertise combined with powerful Gen AI technology. Unlock 2-10 X value, twice as fast

Got a Bussiness Question?

Why Do We Do ?

We believe there is a way to bring novel medicines to patients faster and cost-effectively.

Our Story

What We Do?

We address pain points and solve problems for pharma across the product’s life cycle using
the power of published evidence.

Our Case studies

How?

By using our AI enabling platform that provides valuable insights and solutions with unmatchable speed, quality, and cost.

Check More

Like many clients we served, you would be amazed to see insights you can gain using published evidence and secondary data.

Our platform hosts curated, contextualized, normalized, AI enabling evidence library from high quality industry, regulatory and payer accepted data sources.

Innomagine offers end-to-end strategic, scientific, and creative solutions across Medical Affairs, Scientific Communications, Value & Access, Competitive Intelligence, and Digital Innovation. From evidence gap analysis, KEE engagement, and real-world insights to publication planning, andcongress intelligence, we deliver impactful content and data-driven strategies. Our creative team brings science to life through animations, infographics, and dashboards—empowering smarter decisions and stronger stakeholder engagement.

Discover the power of evidence-driven innovation with Innomagine—your next-gen, AI-enabled partner for strategic, scientific, and creative solutions in pharma and healthcare. Let’s turn insights into impact. From publication planning to real-world evidence, digital storytelling to competitive intelligence, we help you navigate complexity with clarity and purpose.

Explore Case Studies

Innomagine

Who We Are?

We specialize in developing and executing strategies that optimize the positioning of molecules in today’s highly competitive landscape. Our team brings deep experience and expertise across multiple therapeutic areas, including oncology, dermatology, hematology, gastrointestinal disorders, immunology, respiratory, cardiovascular, rare diseases, and neuroscience.

By combining science, creativity, innovation, art, and technology (SciAT), we deliver tailored and effective solutions that help our partners achieve meaningful impact in advancing patient care.

Learn More

Why choose our company

We are expert at bringing together science, technology, and creativity

We deliver solutions – more than just completing assignments

We bring fresh perspective – it is beyond following instructions

Our experienced team looks for possibility amid of challenges and complexities

Endless Edge Capabilities

Medical Affair

  • Evidence gap analysis
  • KEE engagement strategies
  • Literature analysis and surveillance
  • Treatment landscape analysis

Scientific Communications

  • Internal and external education materials
  • Congress intelligence
  • Infographics
  • Interactive slides and PDF
  • Publications
  • Publication planning
  • Interactive bibliography

Value, access and RWE

  • Gap analysis and strategic recommendations
  • Disease burden & epidemiology review
  • RW KEE analysis and insights
  • Integrated evidence plan
  • Systematic literature reviews
  • ITC including NMA
  • Internal and external teaching and training

Latest InsightsView all insights

Real-world evidence: Are you missing important insights by not monitoring independent research?

The evidence is in: From market access to patient centricity, drug developers that conquer these key areas will be best poised...

Read More
Why do medical affairs need an Eagle’s eye?

In today’s rapidly evolving healthcare landscape, medical affairs teams play a critical role in ensuring the safe and effective development, launch,...

Read More
What is publication benchmarking and why you need it for your asset?

In the highly competitive and evolving landscape of novel treatments within any therapeutic area, staying ahead is not just about innovation...

Read More

Got a project in mind?

Let’s make it matter.

Contact us